Developer docs
API playgroundTry for free, no card

Search company profiles

OZ Biosciences

Full company profile

uuid000bylg

Namestring
OZ Biosciences
Legal namestring
OZ Biosciences
Company typeenum
Private
Founded yearint
2002
Descriptiontext

OZ Biosciences is a France-based biotechnology company founded in 2002 that designs, develops, and manufactures molecular delivery systems used by academic, pharmaceutical, and biotechnology researchers worldwide. The firm specializes in transfection and transduction tools spanning four proprietary technology platforms: Magnetofection (magnetic-field-driven delivery), Lipofection (lipid-based reagents such as the DreamFect family), Polyfection (polymer-based delivery), and I-MICST (integrated magnetic immuno-cell sorting and transfection). Its catalog of 140+ reagents includes DNA, siRNA, mRNA, and CRISPR delivery kits; viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast); the NanOZ Lipid Nanoparticle (LNP) platform built on clinically validated SM-102 and MC3 ionizable lipids for organ-selective in vivo delivery; the ExploCap co-transcriptional mRNA/saRNA capping technology; vaccine adjuvants; and cellular assay kits. Custom mRNA synthesis, custom saRNA synthesis, and custom LNP formulation services complement the catalog for research and translational customers.

The company monetizes through direct e-commerce sales from ozbiosciences.com and a hybrid distribution model with 35+ global partners, including ThermoFisher Scientific, VWR (Avantor), Dutscher Group, Funakoshi, and CliniSciences. Pricing is unit-based with significant tier differentiation between research-use-only SKUs ($50-$500 per reaction typical), process-development grades, and the recently launched LentiBlast Premium Superior Grade clinical/CGT-grade SKU ($751-$1,945) carrying USP <63> and USP <85> QC testing. Two primary legal entities, OZ Biosciences SAS in Marseille and OZ Biosciences USA Inc. in San Diego, handle direct sales for EMEA and North America respectively, with stated strategic-alliance pursuits targeting pharma, biotech, and CDMOs for long-term multi-project collaborations. The customer base is horizontally diversified across academic and research institutions and pharmaceutical/biotechnology companies, with secondary use-case segments in 3D biology/organoids, neuroscience, vaccine research, and bioproduction. Independent and privately held, with no disclosed external venture or private equity financing beyond early-stage support from Incubateur Impulse in 2003 and leadership under founder-CEO Olivier Zelphati, the company holds ISO 9001:2015 and French CIR Agreement certifications and reports 2,500+ peer-reviewed publications citing its products.

Short descriptiontext

OZ Biosciences, founded in 2002 in Marseille, France, designs and manufactures proprietary molecular delivery systems for transfection, transduction, mRNA/LNP delivery, and viral production, supplying academic researchers, pharmaceutical companies, biotech firms, and CDMOs across 35+ countries via direct e-commerce and a global distributor network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
transfection reagents, molecular delivery systems, lipid nanoparticles, viral transduction enhancers, mRNA synthesis services
Industry5 codes
PRIMARYHLAAADAD
RNA Delivery Technologies (LNPs, polymers, conjugates incl. GalNAc, peptides, exosomes)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)
SECONDARYHLAAACAC
Non-viral Gene Delivery & Gene Therapy (LNP, polymers, electroporation, physical methods)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAADAF
RNA Manufacturing & CMC (oligo synthesis, IVT, purification, formulation, QC)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)
SECONDARYHLAAADAG
RNA Therapeutics Platforms & Design (sequence design, target ID/validation, AI/bioinformatics)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)
SECONDARYHLAAADAE
RNA Chemistry & Oligonucleotide Engineering (backbones, modifications, stereochemistry)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Life Sciences Reagents (Molecular Delivery / Transfection and Transduction)
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model7 records
1Transfection and Transduction Reagents
TypeOne Time License
Description

Sale of reagents for DNA, siRNA, mRNA, and CRISPR transfection including Magnetofection products, lipofection reagents, and polyfection reagents. One-time product purchases with various sizes available (100 µL to multi-mL kits).

ozbiosciences.com
2Viral Applications Products
TypeOne Time License
Description

Products for virus production, preservation, capture, concentration, and transduction enhancement including LentiBlast, ViroMag, AdenoMag, and AAVBlast. One-time reagent purchases.

ozbiosciences.com
3LNP Products
TypeOne Time License
Description

Lipid Nanoparticle products for mRNA and siRNA delivery including NanOZ LNP kits, fluorescent LNPs, empty LNPs, and DIY formulations. Includes clinically validated SM-102 and MC3 formulations.

ozbiosciences.com
4mRNA and saRNA Products
TypeOne Time License
Description

Cap1 mRNAs and saRNAs for various applications including reporter genes, fluorescent proteins, genome editing, vaccines, gene replacement, cytokines, and transcription factors. Also includes IVT kits, capping kits, and poly(A) kits.

ozbiosciences.com
5Custom Synthesis Services
TypeProfessional Services
Description

Custom mRNA synthesis, custom saRNA synthesis, and custom LNP formulation services. Quote-based pricing for specialized research and development needs.

ozbiosciences.com
6Vaccine Adjuvants
TypeOne Time License
Description

Adjuvant products for protein-based and mRNA/DNA-based vaccines including aluminum gels, DOTAP cationic liposomes, squalene emulsions, Freund's adjuvant, and surface reactive liposomes.

ozbiosciences.com
7Cellular Assay Kits and Transfection Tools
TypeOne Time License
Description

Assay kits for beta-galactosidase, protein dosage, viability, cytotoxicity, alkaline phosphatase, stem cell senescence, and luciferase expression. Also includes antibiotics, luciferin, X-Gal substrate, and transfection controls.

ozbiosciences.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details12 tiers
1LentiBlast Premium 500 µL - Research Use Only Grade
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$211.00 for 500 µL (up to 100 transductions in 24-well plate). Storage: -20°C. Shipping: Room temperature.

ozbiosciences.com
2LentiBlast Premium 1500 µL - Research Use Only Grade
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$433.00 for 1500 µL (up to 300 transductions in 24-well plate). Storage: -20°C. Shipping: Room temperature.

ozbiosciences.com
3LentiBlast Premium Superior Grade 1500 µL - Clinical/Cell & Gene Therapy Grade
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$751.00 for 1500 µL (up to 300 transductions in 24-well plate). Advanced QC including sterility, mycoplasma, endotoxin, NMR, SEC purity. For preclinical and clinical trials.

ozbiosciences.com
4LentiBlast Premium Superior Grade 5 mL - Clinical/Cell & Gene Therapy Grade
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,945.00 for 5 mL (up to 1000 transductions in 24-well plate). Advanced QC specifications.

ozbiosciences.com
5ViroMag 100 µL
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$136.00 for 100 µL (30-500 transductions in 96-well plate). Requires magnetic plate. Storage: +4°C. Shipping: Room temperature.

ozbiosciences.com
6ViroMag 200 µL
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$246.00 for 200 µL (60-1000 transductions in 96-well plate).

ozbiosciences.com
7ViroMag 1 mL
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$922.00 for 1 mL (300-5000 transductions in 96-well plate).

ozbiosciences.com
8ViroMag Starting Kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$752.00-$860.00 for starting kits including magnetic plates and reagent. ViroMag Starting Kit $795, ViroMag Triple Starting Kit $860.

ozbiosciences.com
9HYVIR Reagent 1.5 mL Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$276.00 for HYVIR Reagent 1.5mL + HYVIR Boost 5mL. Lipid-based transfection kit for enhanced viral particles production in HEK-293T. Animal origin free.

ozbiosciences.com
10HYVIR Reagent 3 mL Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$486.00 for 2 x (1.5mL Reagent + 5mL Boost).

ozbiosciences.com
11HYVIR Reagent 15 mL Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,985.00 for HYVIR Reagent 15mL + HYVIR Boost 50mL. For scalable virus production.

ozbiosciences.com
12HYVIR Reagent 30 mL Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$3,620.00 for 2 x (15mL Reagent + 50mL Boost). Large-scale production.

ozbiosciences.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Magnetofection
Description

Magnetic-based transfection technology platform using magnetic nanoparticles for enhanced molecular delivery

ozbiosciences.com
+6 more records
Core offering1 text field

OZ Biosciences designs, develops and produces proprietary molecular delivery systems and reagents — lipid-, polymer- and magnetic-nanoparticle-based transfection and transduction tools — that enable laboratories to deliver DNA, siRNA, mRNA, CRISPR, proteins, antibodies and viral vectors into cells. Its catalog spans DNA/siRNA/mRNA transfection reagents (DreamFect, Lullaby), viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast, HYVIR), a NanOZ Lipid Nanoparticle (LNP) platform for in vivo mRNA/siRNA delivery, Cap1 mRNAs and self-amplifying RNAs with the proprietary ExploCap capping technology, vaccine adjuvants, and cellular assay kits, supplemented by quote-based custom mRNA, saRNA and LNP formulation services for research and preclinical applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • LentiBlast Premium allows achieving same transduction results with lower viral titer while maximizing cell viability with non-toxic formulation
+2 more records
Product overview1 text field

OZ Biosciences is a biotechnology company that creates, develops, and produces innovative molecular delivery systems specialized in transfection and transduction tools for the worldwide scientific community and pharmaceutical industry. The product portfolio centers around core delivery technologies including Magnetofection (magnetic-based transfection), Lipofection (lipid-based transfection), and Polyfection (polymer-based transfection) platforms. Key product lines include: DNA/siRNA/mRNA transfection reagents (DreamFect, Lullaby families); viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast) for lentivirus, adenovirus, and AAV delivery; NanOZ LNP (Lipid Nanoparticle) products for in vivo mRNA and siRNA delivery; mRNA products including Cap1 mRNAs, self-amplifying RNAs (saRNAs), and the proprietary ExploCap capping technology; vaccine adjuvants; cellular assay kits; and custom synthesis services for mRNA, saRNA, and LNP formulation. The company also offers specialized reagents for neuroscience applications (NeuroMag, Glial-Mag), protein delivery, bioproduction, and cell & gene therapy workflows. With over 22 years of expertise, 140+ life sciences reagents developed, and 2500+ publications citing their products, OZ Biosciences serves both research and clinical applications.

Product and service26 records
1DNA Transfection Reagents (DreamFect Family)
CategoryTransfection reagents (DNA)
Description

Lipid-based transfection reagents for DNA delivery into cells, including DreamFect for standard cell lines, DreamFect Gold as a gold-standard formulation, and DreamFect Stem for stem cell-specific applications; for researchers performing DNA transfection in cell lines, primary cells, stem cells, 3D cultures and explants.

2siRNA Transfection Reagents (Lullaby Family)
CategoryTransfection reagents (siRNA)
Description

Reagents for efficient siRNA delivery into cells for gene silencing applications, including variants for cell lines, primary cells, stem cells, 3D transfection and explants.

3mRNA / Viral RNA Transfection Reagents
CategoryTransfection reagents (mRNA)
Description

Transfection reagents optimized for mRNA and viral RNA delivery into cell lines and stem cells.

4CRISPR Cas9 Products
CategoryTransfection reagents (CRISPR)
Description

Transfection reagents and tools specifically designed for CRISPR Cas9 genome editing workflows.

5LentiBlast Premium
CategoryViral transduction enhancer (lentivirus)
Description

Patented chemical transduction enhancer that dramatically increases lentiviral infection and transduction efficiency across adherent and suspension cells, primary cells and cell lines; neutralizes electrostatic repulsion between membranes and viral particles and enhances viral fusion with the cell membrane in a non-toxic formulation.

6LentiBlast Premium Superior Grade
CategoryViral transduction enhancer (lentivirus, clinical grade ancillary material)
Description

Identical formulation to LentiBlast Premium with advanced quality controls — sterility, NMR chemical characterization, SEC purity, mycoplasma testing per USP <63> and endotoxin testing per USP <85> — designed as an ancillary material for preclinical and early-phase clinical trials in cell and gene therapy, including CAR-T workflows.

7ViroMag
CategoryViral transduction reagent (magnetofection, broad virus)
Description

Magnetic nanoparticle formulation based on Magnetofection technology for increasing virus infection and transduction capacities across virus types, dramatically improving transduction with extremely low vector doses; requires a magnetic plate.

8NeuroMag
CategoryMagnetofection reagent (neuroscience)
Description

Magnetic transfection reagent specifically designed for neurons, enabling efficient transfection of neurons from 1 DIV to 20 DIV.

9Glial-Mag
CategoryMagnetofection reagent (glial cells)
Description

Magnetic transfection reagent for microglial cell lines and primary glial cells.

10AAVBlast
CategoryViral transduction enhancer (AAV)
Description

Non-toxic AAV transduction enhancer effective across a wide range of cell types and compatible with various AAV serotypes.

11HYVIR Transfection Reagent
CategoryBioproduction transfection reagent (lentivirus)
Description

Lipid-based transfection kit dedicated to enhancing viral particle production in HEK-293T cells, optimized for co-transfection of four plasmids simultaneously in third-generation lentiviral production systems, completely animal origin free, and scalable across 1.5 mL to 30 mL kit sizes.

12NanOZ LNP-mRNA
CategoryLipid nanoparticle (LNP) in vivo delivery — mRNA
Description

Ready-to-use lipid nanoparticle formulations with organ-selective biodistribution for in vivo mRNA delivery, validated for liver, spleen, multi-organ targeting and immunization applications, using clinically validated SM-102 and MC3 ionizable lipids.

13NanOZ LNP-siRNA
CategoryLipid nanoparticle (LNP) in vivo delivery — siRNA
Description

Lipid nanoparticle formulations for siRNA delivery with precision gene silencing capabilities, including dual-labeled options with GFP, GAPDH and Cy5 for real-time tracking.

14NanOZ LNP-DIY
CategoryLipid nanoparticle (LNP) DIY kit
Description

Customizable LNP lipid mix allowing researchers to formulate their own lipid nanoparticles for specific applications.

15NanOZ Empty-LNP
CategoryLipid nanoparticle (LNP) controls
Description

Empty lipid nanoparticles intended for control experiments and LNP formulation development.

16NanOZ Fluorescent-LNP
CategoryLipid nanoparticle (LNP) fluorescent reagents
Description

Fluorescently labeled LNPs — DiI, DiO and DiR variants — for biodistribution tracking and cellular uptake studies.

17LNP Selection Kit
CategoryLNP formulation screening kit
Description

Kit for screening and selecting optimal LNP formulations for specific delivery applications.

18ExploCap mRNA
CategorymRNA capping technology / capped mRNA
Description

mRNA products using ExploCap, OZ Biosciences' next-generation cap analog technology for co-transcriptional capping with lower degradation risk and improved downstream manufacturability.

19ExploCap saRNA
CategorySelf-amplifying RNA (saRNA)
Description

Self-amplifying RNA products using ExploCap capping technology for enhanced RNA stability and expression.

20Cap1 mRNAs
CategoryCap1 mRNA catalog
Description

Enzymatically capped Cap1 mRNA products spanning reporter genes, fluorescent proteins, genome editing tools, vaccine antigens, gene replacement sequences, cytokines/interleukins and transcription factors.

21Vaccine Adjuvants
CategoryVaccine adjuvants
Description

Adjuvant systems for protein-based and mRNA/DNA-based vaccines, including aluminum gels, DOTAP cationic liposomes, squalene emulsions, Freund's adjuvant and surface reactive liposomes.

22Cellular Assay Kits
CategoryCellular assay kits
Description

Assay kits including Beta-Gal, protein dosage, viability/stress/cytotoxicity, alkaline phosphatase, stem cell senescence and luciferase expression kits, for use alongside transfection and transduction experiments.

23Transfection Booster (CombiMag)
CategoryTransfection booster reagents
Description

Magnetic and non-magnetic transfection booster reagents to enhance transfection efficiency as add-ons to standard transfection protocols.

24Custom mRNA Synthesis Service
CategoryCustom mRNA synthesis service
Description

Quote-based custom mRNA synthesis service with options for various capping technologies, modifications and specific sequences, including Cap1 structure and poly(A) tail, for reporter genes, fluorescent proteins, genome editing, vaccines, gene replacement and cytokines.

25Custom LNP Formulation Service
CategoryCustom LNP formulation service
Description

Quote-based custom lipid nanoparticle formulation service for developing tailored LNP delivery systems for specialized research and development requirements.

26Custom saRNA Synthesis Service
CategoryCustom saRNA synthesis service
Description

Quote-based custom self-amplifying RNA synthesis service for vaccine and therapeutic development applications, leveraging saRNA's replication capability over conventional mRNA.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

ThermoFisher Scientific is one of OZ Biosciences' distributors, providing global reach and access to ThermoFisher's extensive customer base in the life sciences research market.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

VWR (now part of Avantor) distributes OZ Biosciences products, providing laboratory supplies distribution and local support to researchers worldwide.

3Dominique Dutscher / Milian SA Dutscher Group
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

French and European distributor network under the Dutscher Group umbrella, providing local coverage in France and neighboring markets.

ozbiosciences.com
4Funakoshi
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Japanese distributor for OZ Biosciences products, providing local sales and support for the Japanese research market.

ozbiosciences.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

European distributor specializing in research reagents and laboratory supplies, distributing OZ Biosciences products in their market coverage area.

6Additional Global Distributors
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

30+ additional regional distributors including BOCA SCIENTIFIC Inc, Aurogene, AmyJet, Gaia, Joagene, BIO-CONNECT, BIOZOL, CALTAG, NORDIC DIAGNOSTICA, abyntek, Australian Biosearch, Tivan Biotech LTD, Biogenuix, SLS, LabLife Nordic AB, Lucerna-Chem AG, Thomas Scientific, Hölzel Diagnostika, ABBIOTEC, Biotechno Labs, MEDianus Pharma S.A., MOLGEN BIYOTEKNOLOJI, FERMELO Biotec, QUARTZY, Sputnik, and Biogenuix covering markets across Asia, Europe, Americas, Africa, and Oceania.

ozbiosciences.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-term, multi-project collaborations with pharmaceutical and biotech companies or CDMOs. Can include joint investment, preferred supplier agreements, or first-rights of negotiation. Designed to build enduring partnerships for molecular delivery solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliances with CDMOs for cell and gene therapy development, viral vector manufacturing, and vaccine production using OZ Biosciences delivery technologies.

9Academic Institutions
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborations with academic institutions for research tool development and translational applications. Includes participation in EU and internationally funded research projects through grants programs.

ozbiosciences.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Provides LNP formulation technology (NanoAssemblr platform) for mRNA therapeutics and gene therapy development. Direct peer in LNP-based mRNA/siRNA delivery with comparable custom formulation services.

TypeRegional player
Description

Manufactures plasmids, mRNA, and proteins for gene therapy and vaccine developers. Adjacent peer in the gene therapy supply chain, particularly through nucleic acid production services that complement delivery reagent offerings.

TypeDirect peer
Description

Specializes in electroporation-based transfection (Flow Electroporation) for cell therapy manufacturing and gene editing. Comparable in targeting hard-to-transfect cells and clinical-grade delivery, with overlapping customer base in cell & gene therapy.

TypeBroad incumbent
Description

CDMOs offering lipid excipients and LNP formulation services for mRNA therapeutics. Peer in the clinical-grade delivery and manufacturing services category where OZ Biosciences is positioning.

TypeBroad incumbent
Description

Offers Gene Pulser electroporation systems and transfection reagents for research and bioproduction. Broad incumbent in molecular delivery with comparable presence across academic and commercial customer segments.

TypeBroad incumbent
Description

Provides LNP formulation services and custom lipid manufacturing for mRNA therapeutics through its Health Care business. Increasingly significant competitor in the clinical-grade LNP space.

TypeDirect peer
Description

Specializes in transfection reagents for DNA, siRNA, mRNA, and CRISPR delivery, with the TransIT family of products. Direct competitor across virtually every transfection category OZ Biosciences addresses, now with Roche's scale and resources.

TypeEmerging player
Description

Provides custom viral vector production and plasmid services with growing reagent offerings. Emerging peer with comparable service model for lentiviral, AAV, and CRISPR delivery applications.

TypeBroad incumbent
Description

Global life sciences leader offering Lipofectamine transfection reagents and broad cell biology products. Both a major distributor of OZ Biosciences products and a competitor with its own delivery reagent portfolio.

TypeDirect peer
Description

Develops transfection reagents (jetOPTIMUS, INTERFERin) and PEI-based delivery for gene therapy and vaccine manufacturing. Direct competitor in LNP and polymer-based delivery, particularly for bioproduction and viral vector applications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OZ Biosciences

Life Sciences Reagents (Molecular Delivery / Transfection and Transduction)ozbiosciences.com

OZ Biosciences, founded in 2002 in Marseille, France, designs and manufactures proprietary molecular delivery systems for transfection, transduction, mRNA/LNP delivery, and viral production, supplying academic researchers, pharmaceutical companies, biotech firms, and CDMOs across 35+ countries via direct e-commerce and a global distributor network.

What OZ Biosciences does

OZ Biosciences is a France-based biotechnology company founded in 2002 that designs, develops, and manufactures molecular delivery systems used by academic, pharmaceutical, and biotechnology researchers worldwide. The firm specializes in transfection and transduction tools spanning four proprietary technology platforms: Magnetofection (magnetic-field-driven delivery), Lipofection (lipid-based reagents such as the DreamFect family), Polyfection (polymer-based delivery), and I-MICST (integrated magnetic immuno-cell sorting and transfection). Its catalog of 140+ reagents includes DNA, siRNA, mRNA, and CRISPR delivery kits; viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast); the NanOZ Lipid Nanoparticle (LNP) platform built on clinically validated SM-102 and MC3 ionizable lipids for organ-selective in vivo delivery; the ExploCap co-transcriptional mRNA/saRNA capping technology; vaccine adjuvants; and cellular assay kits. Custom mRNA synthesis, custom saRNA synthesis, and custom LNP formulation services complement the catalog for research and translational customers.

The company monetizes through direct e-commerce sales from ozbiosciences.com and a hybrid distribution model with 35+ global partners, including ThermoFisher Scientific, VWR (Avantor), Dutscher Group, Funakoshi, and CliniSciences. Pricing is unit-based with significant tier differentiation between research-use-only SKUs ($50-$500 per reaction typical), process-development grades, and the recently launched LentiBlast Premium Superior Grade clinical/CGT-grade SKU ($751-$1,945) carrying USP <63> and USP <85> QC testing. Two primary legal entities, OZ Biosciences SAS in Marseille and OZ Biosciences USA Inc. in San Diego, handle direct sales for EMEA and North America respectively, with stated strategic-alliance pursuits targeting pharma, biotech, and CDMOs for long-term multi-project collaborations. The customer base is horizontally diversified across academic and research institutions and pharmaceutical/biotechnology companies, with secondary use-case segments in 3D biology/organoids, neuroscience, vaccine research, and bioproduction. Independent and privately held, with no disclosed external venture or private equity financing beyond early-stage support from Incubateur Impulse in 2003 and leadership under founder-CEO Olivier Zelphati, the company holds ISO 9001:2015 and French CIR Agreement certifications and reports 2,500+ peer-reviewed publications citing its products.

OZ Biosciences firmographics

Firmographics
Name
OZ Biosciences
Legal name
OZ Biosciences
Website
https://ozbiosciences.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
OZ Biosciences, founded in 2002 in Marseille, France, designs and manufactures proprietary molecular delivery systems for transfection, transduction, mRNA/LNP delivery, and viral production, supplying academic researchers, pharmaceutical companies, biotech firms, and CDMOs across 35+ countries via direct e-commerce and a global distributor network.
Ownership category
akta.pro rank

OZ Biosciences industry classification

Industry
Product category
Life Sciences Reagents (Molecular Delivery / Transfection and Transduction)
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAADAD
RNA Delivery Technologies (LNPs, polymers, conjugates incl. GalNAc, peptides, exosomes)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)
SECONDARYHLAAACAC
Non-viral Gene Delivery & Gene Therapy (LNP, polymers, electroporation, physical methods)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAADAF
RNA Manufacturing & CMC (oligo synthesis, IVT, purification, formulation, QC)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)
SECONDARYHLAAADAG
RNA Therapeutics Platforms & Design (sequence design, target ID/validation, AI/bioinformatics)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)
SECONDARYHLAAADAE
RNA Chemistry & Oligonucleotide Engineering (backbones, modifications, stereochemistry)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)

Keywords

  • Transfection reagents
  • Molecular delivery systems
  • Lipid nanoparticles
  • Viral transduction enhancers
  • MRNA synthesis services

Where OZ Biosciences is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices2 records

Markets served

OZ Biosciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Transfection and Transduction Reagents: Sale of reagents for DNA, siRNA, mRNA, and CRISPR transfection including Magnetofection products, lipofection reagents, and polyfection reagents. One-time product purchases with various sizes available (100 µL to multi-mL kits).
  2. Viral Applications Products: Products for virus production, preservation, capture, concentration, and transduction enhancement including LentiBlast, ViroMag, AdenoMag, and AAVBlast. One-time reagent purchases.
  3. LNP Products: Lipid Nanoparticle products for mRNA and siRNA delivery including NanOZ LNP kits, fluorescent LNPs, empty LNPs, and DIY formulations. Includes clinically validated SM-102 and MC3 formulations.
  4. mRNA and saRNA Products: Cap1 mRNAs and saRNAs for various applications including reporter genes, fluorescent proteins, genome editing, vaccines, gene replacement, cytokines, and transcription factors. Also includes IVT kits, capping kits, and poly(A) kits.
  5. Custom Synthesis Services: Custom mRNA synthesis, custom saRNA synthesis, and custom LNP formulation services. Quote-based pricing for specialized research and development needs.
  6. Vaccine Adjuvants: Adjuvant products for protein-based and mRNA/DNA-based vaccines including aluminum gels, DOTAP cationic liposomes, squalene emulsions, Freund's adjuvant, and surface reactive liposomes.
  7. Cellular Assay Kits and Transfection Tools: Assay kits for beta-galactosidase, protein dosage, viability, cytotoxicity, alkaline phosphatase, stem cell senescence, and luciferase expression. Also includes antibiotics, luciferin, X-Gal substrate, and transfection controls.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goLentiBlast Premium 500 µL - Research Use Only Grade
Unit PricingPay-as-you-goLentiBlast Premium 1500 µL - Research Use Only Grade
Unit PricingPay-as-you-goLentiBlast Premium Superior Grade 1500 µL - Clinical/Cell & Gene Therapy Grade
Unit PricingPay-as-you-goLentiBlast Premium Superior Grade 5 mL - Clinical/Cell & Gene Therapy Grade
Unit PricingPay-as-you-goViroMag 100 µL
Unit PricingPay-as-you-goViroMag 200 µL
Unit PricingPay-as-you-goViroMag 1 mL
Unit PricingPay-as-you-goViroMag Starting Kits
Unit PricingPay-as-you-goHYVIR Reagent 1.5 mL Kit
Unit PricingPay-as-you-goHYVIR Reagent 3 mL Kit
Unit PricingPay-as-you-goHYVIR Reagent 15 mL Kit
Unit PricingPay-as-you-goHYVIR Reagent 30 mL Kit

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

OZ Biosciences product offering

Product offering

Core offering

OZ Biosciences designs, develops and produces proprietary molecular delivery systems and reagents — lipid-, polymer- and magnetic-nanoparticle-based transfection and transduction tools — that enable laboratories to deliver DNA, siRNA, mRNA, CRISPR, proteins, antibodies and viral vectors into cells. Its catalog spans DNA/siRNA/mRNA transfection reagents (DreamFect, Lullaby), viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast, HYVIR), a NanOZ Lipid Nanoparticle (LNP) platform for in vivo mRNA/siRNA delivery, Cap1 mRNAs and self-amplifying RNAs with the proprietary ExploCap capping technology, vaccine adjuvants, and cellular assay kits, supplemented by quote-based custom mRNA, saRNA and LNP formulation services for research and preclinical applications.

Product overview

OZ Biosciences is a biotechnology company that creates, develops, and produces innovative molecular delivery systems specialized in transfection and transduction tools for the worldwide scientific community and pharmaceutical industry. The product portfolio centers around core delivery technologies including Magnetofection (magnetic-based transfection), Lipofection (lipid-based transfection), and Polyfection (polymer-based transfection) platforms. Key product lines include: DNA/siRNA/mRNA transfection reagents (DreamFect, Lullaby families); viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast) for lentivirus, adenovirus, and AAV delivery; NanOZ LNP (Lipid Nanoparticle) products for in vivo mRNA and siRNA delivery; mRNA products including Cap1 mRNAs, self-amplifying RNAs (saRNAs), and the proprietary ExploCap capping technology; vaccine adjuvants; cellular assay kits; and custom synthesis services for mRNA, saRNA, and LNP formulation. The company also offers specialized reagents for neuroscience applications (NeuroMag, Glial-Mag), protein delivery, bioproduction, and cell & gene therapy workflows. With over 22 years of expertise, 140+ life sciences reagents developed, and 2500+ publications citing their products, OZ Biosciences serves both research and clinical applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Magnetofection: Magnetic-based transfection technology platform using magnetic nanoparticles for enhanced molecular delivery
  • NanOZ-LNP
  • ExploCap
  • LentiBlast
  • HYVIR
  • DreamFect
  • NeuroMag

Products and services

  • DNA Transfection Reagents (DreamFect Family) Lipid-based transfection reagents for DNA delivery into cells, including DreamFect for standard cell lines, DreamFect Gold as a gold-standard formulation, and DreamFect Stem for stem cell-specific applications; for researchers performing DNA transfection in cell lines, primary cells, stem cells, 3D cultures and explants.
  • siRNA Transfection Reagents (Lullaby Family) Reagents for efficient siRNA delivery into cells for gene silencing applications, including variants for cell lines, primary cells, stem cells, 3D transfection and explants.
  • mRNA / Viral RNA Transfection Reagents Transfection reagents optimized for mRNA and viral RNA delivery into cell lines and stem cells.
  • CRISPR Cas9 Products Transfection reagents and tools specifically designed for CRISPR Cas9 genome editing workflows.
  • LentiBlast Premium Patented chemical transduction enhancer that dramatically increases lentiviral infection and transduction efficiency across adherent and suspension cells, primary cells and cell lines; neutralizes electrostatic repulsion between membranes and viral particles and enhances viral fusion with the cell membrane in a non-toxic formulation.
  • LentiBlast Premium Superior Grade Identical formulation to LentiBlast Premium with advanced quality controls — sterility, NMR chemical characterization, SEC purity, mycoplasma testing per USP <63> and endotoxin testing per USP <85> — designed as an ancillary material for preclinical and early-phase clinical trials in cell and gene therapy, including CAR-T workflows.
  • ViroMag Magnetic nanoparticle formulation based on Magnetofection technology for increasing virus infection and transduction capacities across virus types, dramatically improving transduction with extremely low vector doses; requires a magnetic plate.
  • NeuroMag Magnetic transfection reagent specifically designed for neurons, enabling efficient transfection of neurons from 1 DIV to 20 DIV.
  • Glial-Mag Magnetic transfection reagent for microglial cell lines and primary glial cells.
  • AAVBlast Non-toxic AAV transduction enhancer effective across a wide range of cell types and compatible with various AAV serotypes.
  • HYVIR Transfection Reagent Lipid-based transfection kit dedicated to enhancing viral particle production in HEK-293T cells, optimized for co-transfection of four plasmids simultaneously in third-generation lentiviral production systems, completely animal origin free, and scalable across 1.5 mL to 30 mL kit sizes.
  • NanOZ LNP-mRNA Ready-to-use lipid nanoparticle formulations with organ-selective biodistribution for in vivo mRNA delivery, validated for liver, spleen, multi-organ targeting and immunization applications, using clinically validated SM-102 and MC3 ionizable lipids.
  • NanOZ LNP-siRNA Lipid nanoparticle formulations for siRNA delivery with precision gene silencing capabilities, including dual-labeled options with GFP, GAPDH and Cy5 for real-time tracking.
  • NanOZ LNP-DIY Customizable LNP lipid mix allowing researchers to formulate their own lipid nanoparticles for specific applications.
  • NanOZ Empty-LNP Empty lipid nanoparticles intended for control experiments and LNP formulation development.
  • NanOZ Fluorescent-LNP Fluorescently labeled LNPs — DiI, DiO and DiR variants — for biodistribution tracking and cellular uptake studies.
  • LNP Selection Kit Kit for screening and selecting optimal LNP formulations for specific delivery applications.
  • ExploCap mRNA mRNA products using ExploCap, OZ Biosciences' next-generation cap analog technology for co-transcriptional capping with lower degradation risk and improved downstream manufacturability.
  • ExploCap saRNA Self-amplifying RNA products using ExploCap capping technology for enhanced RNA stability and expression.
  • Cap1 mRNAs Enzymatically capped Cap1 mRNA products spanning reporter genes, fluorescent proteins, genome editing tools, vaccine antigens, gene replacement sequences, cytokines/interleukins and transcription factors.
  • Vaccine Adjuvants Adjuvant systems for protein-based and mRNA/DNA-based vaccines, including aluminum gels, DOTAP cationic liposomes, squalene emulsions, Freund's adjuvant and surface reactive liposomes.
  • Cellular Assay Kits Assay kits including Beta-Gal, protein dosage, viability/stress/cytotoxicity, alkaline phosphatase, stem cell senescence and luciferase expression kits, for use alongside transfection and transduction experiments.
  • Transfection Booster (CombiMag) Magnetic and non-magnetic transfection booster reagents to enhance transfection efficiency as add-ons to standard transfection protocols.
  • Custom mRNA Synthesis Service Quote-based custom mRNA synthesis service with options for various capping technologies, modifications and specific sequences, including Cap1 structure and poly(A) tail, for reporter genes, fluorescent proteins, genome editing, vaccines, gene replacement and cytokines.
  • Custom LNP Formulation Service Quote-based custom lipid nanoparticle formulation service for developing tailored LNP delivery systems for specialized research and development requirements.
  • Custom saRNA Synthesis Service Quote-based custom self-amplifying RNA synthesis service for vaccine and therapeutic development applications, leveraging saRNA's replication capability over conventional mRNA.

Quantifiable outcome

  • LentiBlast Premium allows achieving same transduction results with lower viral titer while maximizing cell viability with non-toxic formulation
  • +2 more outcomes

Companies that use OZ Biosciences

Customer profile

Segments6 records

Ideal customer profiles4 records

OZ Biosciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature11 records

OZ Biosciences partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered major, regional, core and minor.

  • ThermoFisher ScientificmajorChannel Partner/ Reseller/ DistributorThermoFisher Scientific is one of OZ Biosciences' distributors, providing global reach and access to ThermoFisher's extensive customer base in the life sciences research market.
  • VWR (Avantor)majorChannel Partner/ Reseller/ DistributorVWR (now part of Avantor) distributes OZ Biosciences products, providing laboratory supplies distribution and local support to researchers worldwide.
  • Dominique Dutscher / Milian SA Dutscher GroupmajorChannel Partner/ Reseller/ DistributorFrench and European distributor network under the Dutscher Group umbrella, providing local coverage in France and neighboring markets.
  • FunakoshiregionalChannel Partner/ Reseller/ DistributorJapanese distributor for OZ Biosciences products, providing local sales and support for the Japanese research market.
  • CliniSciencesregionalChannel Partner/ Reseller/ DistributorEuropean distributor specializing in research reagents and laboratory supplies, distributing OZ Biosciences products in their market coverage area.
  • Additional Global DistributorsregionalChannel Partner/ Reseller/ Distributor30+ additional regional distributors including BOCA SCIENTIFIC Inc, Aurogene, AmyJet, Gaia, Joagene, BIO-CONNECT, BIOZOL, CALTAG, NORDIC DIAGNOSTICA, abyntek, Australian Biosearch, Tivan Biotech LTD, Biogenuix, SLS, LabLife Nordic AB, Lucerna-Chem AG, Thomas Scientific, Hölzel Diagnostika, ABBIOTEC, Biotechno Labs, MEDianus Pharma S.A., MOLGEN BIYOTEKNOLOJI, FERMELO Biotec, QUARTZY, Sputnik, and Biogenuix covering markets across Asia, Europe, Americas, Africa, and Oceania.
  • Pharma and Biotech Companies (Strategic Alliances)coreStrategic or Co-development PartnerLong-term, multi-project collaborations with pharmaceutical and biotech companies or CDMOs. Can include joint investment, preferred supplier agreements, or first-rights of negotiation. Designed to build enduring partnerships for molecular delivery solutions.
  • CDMOs (Contract Development and Manufacturing Organizations)coreStrategic or Co-development PartnerStrategic alliances with CDMOs for cell and gene therapy development, viral vector manufacturing, and vaccine production using OZ Biosciences delivery technologies.
  • Academic InstitutionsminorStrategic or Co-development PartnerCollaborations with academic institutions for research tool development and translational applications. Includes participation in EU and internationally funded research projects through grants programs.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

OZ Biosciences competitors and assessment

Company assessment

Direct peers

  • Precision Nanosystems (Cytiva): Provides LNP formulation technology (NanoAssemblr platform) for mRNA therapeutics and gene therapy development. Direct peer in LNP-based mRNA/siRNA delivery with comparable custom formulation services.
  • MaxCyte: Specializes in electroporation-based transfection (Flow Electroporation) for cell therapy manufacturing and gene editing. Comparable in targeting hard-to-transfect cells and clinical-grade delivery, with overlapping customer base in cell & gene therapy.
  • Mirus Bio (Roche): Specializes in transfection reagents for DNA, siRNA, mRNA, and CRISPR delivery, with the TransIT family of products. Direct competitor across virtually every transfection category OZ Biosciences addresses, now with Roche's scale and resources.
  • Polyplus (Sartorius): Develops transfection reagents (jetOPTIMUS, INTERFERin) and PEI-based delivery for gene therapy and vaccine manufacturing. Direct competitor in LNP and polymer-based delivery, particularly for bioproduction and viral vector applications.

Regional players

  • Aldevron: Manufactures plasmids, mRNA, and proteins for gene therapy and vaccine developers. Adjacent peer in the gene therapy supply chain, particularly through nucleic acid production services that complement delivery reagent offerings.

Broad incumbents

  • CordenPharma: CDMOs offering lipid excipients and LNP formulation services for mRNA therapeutics. Peer in the clinical-grade delivery and manufacturing services category where OZ Biosciences is positioning.
  • Bio-Rad Laboratories: Offers Gene Pulser electroporation systems and transfection reagents for research and bioproduction. Broad incumbent in molecular delivery with comparable presence across academic and commercial customer segments.
  • Evonik: Provides LNP formulation services and custom lipid manufacturing for mRNA therapeutics through its Health Care business. Increasingly significant competitor in the clinical-grade LNP space.
  • Thermo Fisher Scientific: Global life sciences leader offering Lipofectamine transfection reagents and broad cell biology products. Both a major distributor of OZ Biosciences products and a competitor with its own delivery reagent portfolio.

Emerging players

  • Vector Builder: Provides custom viral vector production and plasmid services with growing reagent offerings. Emerging peer with comparable service model for lentiviral, AAV, and CRISPR delivery applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

OZ Biosciences social profiles

Digital presence

OZ Biosciences compliance and trust

Trust signal

Compliance2 records

OZ Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OZ Biosciences leadership team

Management profile

Number of profiles

Profiles1 record

OZ Biosciences funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OZ Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OZ Biosciences

What does OZ Biosciences do?

OZ Biosciences designs, develops and produces proprietary molecular delivery systems and reagents — lipid-, polymer- and magnetic-nanoparticle-based transfection and transduction tools — that enable laboratories to deliver DNA, siRNA, mRNA, CRISPR, proteins, antibodies and viral vectors into cells. Its catalog spans DNA/siRNA/mRNA transfection reagents (DreamFect, Lullaby), viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast, HYVIR), a NanOZ Lipid Nanoparticle (LNP) platform for in vivo mRNA/siRNA delivery, Cap1 mRNAs and self-amplifying RNAs with the proprietary ExploCap capping technology, vaccine adjuvants, and cellular assay kits, supplemented by quote-based custom mRNA, saRNA and LNP formulation services for research and preclinical applications.

Is OZ Biosciences a public or private company?

OZ Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was OZ Biosciences founded?

OZ Biosciences was founded in 2002. It employs 11 to 50 people.

Where is OZ Biosciences based?

OZ Biosciences is headquartered in San Diego, United States, in the North America region.

How does OZ Biosciences make money?

Seven revenue lines are on record. Transfection and Transduction Reagents are the primary driver. The others are viral Applications Products, LNP Products, mRNA and saRNA Products, custom Synthesis Services, vaccine Adjuvants and cellular Assay Kits and Transfection Tools.

Who are OZ Biosciences's main competitors?

Direct peers on record are Precision Nanosystems (Cytiva), MaxCyte, Mirus Bio (Roche) and Polyplus (Sartorius). Aldevron is listed as a regional player. Broad incumbents are CordenPharma, Bio-Rad Laboratories, Evonik and Thermo Fisher Scientific. Vector Builder is listed as an emerging player.

Does OZ Biosciences have an API?

No public API is recorded for OZ Biosciences.

What industry is OZ Biosciences in?

OZ Biosciences's product category is Life Sciences Reagents (Molecular Delivery / Transfection and Transduction). Its primary akta.pro industry code is HLAAADAD, RNA Delivery Technologies (LNPs, polymers, conjugates incl. GalNAc, peptides, exosomes), with a secondary code of HLAAACAC, Non-viral Gene Delivery & Gene Therapy (LNP, polymers, electroporation, physical methods). Its NAICS code is 541714 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals